LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-08-14
Case ID: NM_002691.4_c.2959del_20260814_031315
Framework: ACMG/AMP 2015
Variant classification summary

NM_002691.4:c.2959del

POLD1  · NP_002682.2:p.(Asp987ThrfsTer58)  · NM_002691.4
GRCh37: chr19:50919865 AG>A  ·  GRCh38: chr19:50416608 AG>A
Gene: POLD1 Transcript: NM_002691.4
Final call
Likely Pathogenic
PVS1 very strong PM2 supporting
All criteria require review: For research and educational purposes only.
Gene
POLD1
Transcript
NM_002691.4
Protein
NP_002682.2:p.(Asp987ThrfsTer58)
gnomAD AF
5.7738350325515986e-06 (v4.1)
ClinVar
Uncertain significance
OncoKB
Unknown Oncogenic Effect
Interpretation summary
Generated evidence synthesis
1
PVS1 (Very Strong): frameshift p.(Asp987ThrfsTer58) introduces a premature stop 58 codons downstream, predicted to trigger nonsense-mediated decay.
2
PM2 (Supporting): overall allele frequency 5.77e-06 in gnomAD v4.1, far below the 0.1% threshold, with no homozygotes.
3
Overall: Likely Pathogenic — PVS1 (Very Strong) plus PM2 (Supporting) under the ClinGen SVI 2020 PM2-downgrade addendum (PVS1 + 1 supporting).
Final determination: PVS1 (very strong) + PM2 (supporting) combine to Likely Pathogenic per the ClinGen SVI 2020 PM2-downgrade addendum.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 Met Met (Very Strong): frameshift creates a premature stop codon 58 codons downstream, predicted to trigger nonsense-mediated decay.
pvs1_gene_context pvs1_variant_assessment pvs1_generic_framework clinvar
PS1 N/A Not applicable: frameshift produces no altered amino acid, so there is no residue to compare against a previously established pathogenic change.
generic_acmg_combination_rules
PS2 Not assessed Not assessed: no parental testing or de novo confirmation for this variant was documented.
PS3 Not assessed Not assessed: no functional assay data for this exact variant was available.
PS4 Not assessed Not assessed: no case-control counts or qualifying case series for this exact variant were available.
PMID:23263490 PMID:23447401
PM1 N/A Not applicable: PM1 requires a missense variant; this frameshift leaves no altered residue to evaluate for hotspot membership.
generic_acmg_combination_rules
PM2 Met Met (Supporting): allele frequency 5.77e-06 in gnomAD v4.1, far below the 0.1% threshold. Flagged for human review: a ClinVar submitter noted gnomAD frequency data at this position may be unreliable.
gnomad_v4 gnomad_v2 gnomad_canada clinvar
PM3 N/A Not applicable: POLD1 disease here is dominant, with no evidence of a recessive disorder requiring trans configuration.
PM4 N/A Not applicable: PM4 applies to in-frame indels or stop-loss changes; this frameshift causes no protein length change.
pvs1_generic_framework generic_acmg_combination_rules
PM5 N/A Not applicable: PM5 requires a missense change at this residue; this frameshift creates no missense to compare.
generic_acmg_combination_rules
PM6 Not assessed Not assessed: no parental testing or clinical context supporting an assumed de novo occurrence was documented.
PP1 Not assessed Not assessed: no affected relatives, informative meioses, or segregation data for this variant were documented.
PP2 N/A Not applicable: PP2 applies only to missense variants; this frameshift involves no missense change.
generic_acmg_combination_rules
PP3 N/A Not applicable: PP3 concerns missense/synonymous splicing predictions; no in-silico scores apply to this frameshift.
PP4 Not assessed Not assessed: no patient-level phenotype or family-history data specific to this case was available.
PP5 Not met Not met: ClinVar variation 935838 has only two Uncertain-significance laboratory submissions and no expert-panel classification.
clinvar
BA1 Not met Not met: highest observed allele frequency 5.53e-05 is far below the 1% BA1 threshold.
gnomad_v4 gnomad_v2
BS1 Not met Not met: highest observed allele frequency 5.53e-05 is far below the 0.3% BS1 threshold.
gnomad_v4 gnomad_v2
BS2 Not assessed Not assessed: no phenotype-confirmed healthy-adult observation exists; zero homozygotes alone are insufficient.
gnomad_v4 gnomad_v2
BS3 Not assessed Not assessed: no functional assay data for this variant was available to demonstrate normal function.
BS4 Not assessed Not assessed: no tested relatives or non-segregation observations were documented for this variant.
BP1 N/A Not applicable: BP1 applies only to missense variants; this frameshift involves no missense change.
generic_acmg_combination_rules
BP2 Not assessed Not assessed: no data on phase with another variant (trans or cis) was available.
BP3 N/A Not applicable: BP3 concerns in-frame indels in repetitive regions; this frameshift does not qualify.
pvs1_generic_framework generic_acmg_combination_rules
BP4 N/A Not applicable: BP4 requires missense/synonymous in-silico scores; none apply to this frameshift.
BP5 Not assessed Not assessed: no alternative molecular cause for the patient's phenotype was documented.
BP6 Not met Not met: ClinVar variation 935838 has only two Uncertain-significance laboratory submissions and no expert-panel classification.
clinvar
BP7 N/A Not applicable: BP7 applies to synonymous variants; this frameshift alters the encoded protein sequence.
generic_acmg_combination_rules
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.